Deborah Doroshow
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer (NCT04997993) | Deborah Doroshow | 2023-12-13 |
Track Deborah Doroshow automatically
Every clearance here is in the API, with alerts when new ones post.